Latest news
State Street Corporation (CTMX) reports 5.4% beneficial stake in CytomX Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 13:21:14 GMTCytomX enrolls 113 patients; next colorectal cancer trial planned - Stock TitanStock Titan · Thu, 06 Aug 2026 20:15:00 GMTCytomX Therapeutics, Inc. (CTMX) awards 450,000 options and 100,000 RSUs to CLO - Stock TitanStock Titan · Wed, 05 Aug 2026 23:33:53 GMTCytomX Therapeutics, Inc. (CTMX) Chief Legal Officer files Form 3 insider report - Stock TitanStock Titan · Wed, 05 Aug 2026 23:32:38 GMTBank of America (NYSE: BAC) discloses 7.0% ownership stake in CytomX (CTMX) - Stock TitanStock Titan · Mon, 03 Aug 2026 16:06:06 GMTCytomX's second-quarter results call is set for Aug. 6 at 5 p.m. ET - Stock TitanStock Titan · Thu, 30 Jul 2026 07:00:00 GMT